Procainamide Antibody (708): sc-66077

Procainamide Antibody (708) is a mouse monoclonal IgG2a light chain antibody that detects Procainamide in non-species reactive samples by enzyme-linked immunosorbent assay (ELISA). Procainamide is a class Ia antiarrhythmic drug that plays a crucial role in managing cardiac arrhythmias by inhibiting sodium channels, which prolongs cardiac action potential and slows conduction velocity. This mechanism helps restore normal heart rhythm and can prevent potentially life-threatening arrhythmias. Anti-Procainamide antibody (708) allows for precise quantification and monitoring of drug levels in clinical settings, which is essential for optimizing therapeutic efficacy and minimizing adverse effects. Notably, Procainamide is metabolized into N-acetyl procainamide, an active metabolite that is excreted through the renal system, making the understanding of its pharmacokinetics and interactions critical for patient safety. Procainamide (708) antibody serves as an invaluable tool for researchers and clinicians, facilitating the study of drug interactions and assessment of immune responses that may arise from its use, such as the potential for systemic lupus erythematosus-like reactions.